We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DIA 2021 Annual Meeting: FDA Officials Highlight Priorities for Generics Inspections
DIA 2021 Annual Meeting: FDA Officials Highlight Priorities for Generics Inspections
The FDA is prioritizing preapproval inspections of generics based on whether the products can alleviate drug shortages, agency officials said at the Drug Information Association (DIA)’s 2021 global annual meeting yesterday.